Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial

https://www.thelancet.com/collections/obstetrics-gynaecology?dgcid=hubspot_email_infocusalerts-obgyn_feature&parent=001603&startPage=&ContentItemType=fla&utm_campaign=infocusalerts-obgyn&utm_medium=email&_hsenc=p2ANqtz-9mKW4eK_Iqp5ViuNNH4tupzUm1a2axzidCeRcmsEjCornHAWQnVAbmNrkQ9q6AesnO1qecrRTcEBpg8xnLXJ9pRKJMOA&_hsmi=334137311&utm_content=333916803&utm_source=hs_email